Parnax Lab Ltd Share Price

Pharmaceuticals - Indian - FormulationsNSE
₹114.87
+1.46+1.29% (1D)
As on 20 Nov 2026 at 15:55
As of 20 Nov 2026 at 15:55, Parnax Lab Ltd is trading at ₹114.87. The 52-week range stands at ₹90.00–₹182.00, with a market cap of ₹133.12 crore. At a P/E of 170.44 and a dividend yield of 0.00%, it is a small-cap stock in the Pharmaceuticals sector.

PARNAXLAB Price Chart

Market Cap
₹133.12 Cr
PE Ratio
170.44
ROCE
1.59%

Parnax Lab Ltd Performance

Parnax Lab Ltd Fundamentals

Know More
Market Cap₹133.12 Cr
ROE3.13%
P/E Ratio (TTM)170.44
EPS (TTM)₹0.68
P/B Ratio5.54
Dividend Yield0.00%
Industry P/E91.72
Book Value₹20.91
Debt to Equity0.00
Face Value₹10

Parnax Lab Ltd Shareholding Pattern

Know More
Promoter72.3%
Foreign Institutions0%
Mutual Funds0%
Domestic Institutions0%
Public27.7%

Parnax Lab Ltd Financial Statements

Know More
No data for this view.

Parnax Lab Ltd Peer Comparison

Know More
StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Sun Pharmaceutical Industries Ltd
₹1,885.10
-14.90(-0.78%)
4,52,298.61,583.7 - 2,046.9
Torrent Pharmaceuticals Ltd
₹4,698.80
87.80(+1.90%)
1,78,727.33,672.3 - 5,250.0
Dr Reddys Laboratories Ltd
₹1,390.50
-10.40(-0.74%)
1,16,144.51,101.0 - 1,414.9
Cipla Ltd
₹1,414.95
-3.55(-0.25%)
1,14,312.11,165.7 - 1,539.7
Lupin Ltd
₹2,010.00
11.20(+0.56%)
91,915.91,892.9 - 2,529.5

About Parnax Lab

Parnax Lab Limited, formerly Known as Krishna Deep Trade & Investment Limited was incorporated in August, 1982. The Company changed the name from Krishna Deep Trade & Investment Ltd to Parnax Lab Limited with effect from July 19, 2012. The Company engages in the business activities of manufacturing and export of Pharmaceutical Formulations. Initially, it was engaged in investment and financing activities. Naxpar Pharma Private Limited is Subsidiary Company of the Holding Company. With over two decades of rich experience behind it, the Naxpar Group is at the helm of innovation in the manufacturing of Pharmaceuticals, Cosmetics, Herbal/Ayurvedic formulations & Nutraceuticals (FSSAI) products. The Naxpar Group is headquartered in Mumbai, India. It is as a result of their diligence and perseverance that Naxpar's prowess in pharmaceutical manufacturing has seen exponential growth and achievement, significant milestones such as the coveted ISO 9002 status from RWTUV, Germany for following Good Quality Systems in manufacturing and marketing of formulations for domestic and international markets. Naxpar initially began as a single-establishment - indicative of its resounding success and growing client base, the Company has state-of-the-art accredited manufacturing facilities with high speed packing lines in Silvassa, in Dadra & Nagar Haveli and Baddi in Himachal Pradesh. Naxpar's key strength is manufacturing finished formulations for multinationals in India and abroad and in emerging pharmaceutical markets such as Nigeria, Kazakhstan, Kenya, Mauritius etc. The WHO-approved and EHS-compliant Company is now well placed to venture into markets such as South East Asia, CIS, LatAm etc. where it is keen to establish its presence as a leading pharmaceuticals, cosmetics and herbal products manufacturer.

Parent Organisation—
Founded1982
Managing DirectorMihir Prakash Shah
NSE SymbolPARNAXLAB

Parnax Lab Ltd Resistance and Support levels

R3130.39R2124.97R1121.62S1110.78S2107.43S3102.01114.87

Parnax Lab Ltd Technicals

Current Price
₹114.87 ₹1.46 (+1.29%)
Bearish
4
Bullish
8
  • 20 Day4.7%
  • 50 Day0.2%
  • 100 Day1.8%
  • 200 Day1.8%

Parnax Lab Ltd Latest News

View More
23 OCT 2026 | Friday
Parnax Lab Ltd leads gainers in 'B' group
22 MAY 2026 | Friday
Parnax Lab schedules board meeting

2026

Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial
Annual ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial

Frequently asked questions

The share price of Parnax Lab Ltd is ₹114.87 as of 20 Nov 2026 at 15:55.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now